Photophobia clinical trials
The registry lists 29 studies for Photophobia across more than 10 countries. 13 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-24.
Status
- Completed
- 11
- Recruiting
- 10
- Not yet recruiting
- 3
- Withdrawn
- 2
- Terminated
- 2
- Status unknown
- 1
Phase
- Phase 3
- 4
- Phase 4
- 1
Where
- United States
- 20
- Spain
- 3
- Poland
- 3
- United Kingdom
- 3
- Germany
- 3
- Japan
- 2
Who runs them
Pfizer (4) · Ohio State University (2) · The University of Texas Medical Branch, Galveston (1) · Cynthia Owsley (1) · University of Alabama at Birmingham (1) · Kaiser Permanente (1) · Medical University of Vienna (1) · Randy Kardon (1)
Studies
Recruiting first, then most recently updated. Showing 29 of 29 — search for more.
- Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of MigraineRecruitingNCT04743141Phase 33 countries
- Randomized Study in Children and Adolescents With Migraine: Acute TreatmentRecruitingNCT04649242Phase 39 countries
- Objectively Diagnose and Monitor Treatment of Light SensitivityRecruitingNCT03694626Not applicable1 country
- Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric SubjectsRecruitingNCT05156398Phase 37 countries
- Examining Lithium's Mechanism in Bipolar DisorderNot yet recruitingNCT07750925Not applicable1 country
- Use of Tinted Contact Lenses for Concussion-Related Light SensitivityRecruitingNCT07223086Not applicable1 country
- Effect of Fixation Training With Colored Light Targets on Traumatic Brain Injury-Associated PhotophobiaRecruitingNCT07606300Not applicable1 country
- Comparison Between Spectacles and Contact LensesNot yet recruitingNCT06905912Not applicable1 country
- Light Exposure, Migraine Outcomes, and Sleep QualityRecruitingNCT07476053Not applicable1 country
- Investigating Brain Function in People With and Without Visual Snow Syndrome Using Adaptation to Visual StimuliRecruitingNCT06961864Not applicable1 country
- Pilot Study of Neurofeedback for Photosensitivity in Mild Traumatic Brain InjuryRecruitingNCT06109909Not applicable1 country
- Migraine Headache Mitigation Utilizing AvuluxNot yet recruitingNCT06149000Not applicable
- Eye Movement Behaviour and Pupil Size in Natural Outdoor and Indoor ScenesRecruitingNCT05971238Not applicable1 country
- Functionally Validated Structural Endpoints for Early AMDCompletedNCT041126671 country
- Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine PreventionCompletedNCT05207865Phase 41 country
- Impact Of Everyday Light Exposure Patterns On HealthCompletedNCT06908395Not applicable1 country
- Improving Glare and Visual Comfort for Patients With Visual ImpairmentWithdrawnNCT05829135Not applicable1 country
- The Role of Spectral Filtering in a Spectrally Adjustable Ocular Photosensitivity AnalyzerCompletedNCT04811079Not applicable1 country
- Performance and Tolerability of the Medical Device LACRIACTCompletedNCT06159569Not applicable1 country
- Mindfulness Based Cognitive Therapy Modified for Visual Symptoms (MBCT-vision)CompletedNCT04184726Not applicable1 country
- Biomarker for Cystinosis Disease: BioCystinosis (BioCystinosis)WithdrawnNCT028375233 countries
- Thin Film Spectacle Coatings to Reduce Light Sensitivity and Headaches in Child and Adolescent Patients With MigraineTerminatedNCT01942486Not applicable1 country
- How Can we Treat Photophobia in MigraineCompletedNCT05369910Not applicable
- Light at Night StudyTerminatedNCT04251234Not applicable1 country
- Functional MRI Study of Cortical Modifications to Light Stimulation in Patients With PhotophobiaStatus unknownNCT03464357Not applicable1 country
- The Head Injury-associated Photosensitivity and Pupillary Function (HIPP) StudyCompletedNCT019425641 country
- Thin Film Spectacle Coatings to Reduce Light Sensitivity and Headaches in Patients With MigraineCompletedNCT01828684Not applicable1 country
- "Eye Protection After Mydriatic Use for ROP Screening: Impact on Vitals Signs and Pain Scores"CompletedNCT01860534Not applicable1 country
- An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine AttackCompletedNCT00330850Phase 31 country